JLK

JLK Interest Coverage

The Interest Coverage Ratio of JLK (322510.KQ) as of Nov 3, 2026 is -18.02. In the previous year, Interest Coverage Ratio was -52.91 — a change of -65.95% (higher).

Interest Coverage

-18.02

YoY

-65.95%

Last updated:

Interest Coverage Ratio of JLK is 2024 -18.02 . Interest Coverage Ratio of JLK was 2023 -52.91 . It decreases by -65.95% higher compared to the previous year.

The JLK Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-0.91 KRW
Jan 1, 2018
-2.92 KRW
Jan 1, 2019
-55.98 KRW
Jan 1, 2020
-118.76 KRW
Jan 1, 2021
-21.41 KRW
Jan 1, 2022
-22.97 KRW
Jan 1, 2023
-52.91 KRW
Jan 1, 2024
-18.02 KRW
The JLK Interest Coverage history
YEARInterest CoverageYoY
-18.02-65.95%
-52.91+130.31%
-22.97+7.29%
-21.41-81.97%
-118.76+112.12%
-55.98+1,814.02%
-2.92+219.84%
-0.91—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JLK Stock analysis

What does JLK do? JLK, Inc. generates revenue through AI medical analysis solutions, AI industry and security analysis solutions, and AI medical diagnostic platforms. The company's products include AI medical systems, AI quantitative analysis platforms, and AI remote platforms, which are sold to healthcare providers and medical institutions. The primary customer segments are hospitals and clinics seeking advanced diagnostic tools for brain disease detection. Revenue streams are derived from software licensing and subscription services for these AI-driven diagnostic systems. JLK, Inc. focuses on developing AI-based data-driven diagnostic systems specifically for brain disease detection. The company's AI medical diagnostic platforms are designed to provide accurate and efficient analysis for medical professionals. These platforms are part of the broader suite of AI medical analysis solutions that include AI quantitative analysis and AI remote platforms. The firm's target market includes healthcare facilities requiring cutting-edge technology for neurological diagnostics. The company's software products, such as AI medical systems and AI quantitative analysis platforms, are marketed to healthcare institutions for integration into their diagnostic workflows. Revenue is primarily generated through licensing agreements and recurring subscription fees for access to the AI-driven diagnostic tools. These solutions are positioned as essential for modern healthcare providers aiming to enhance diagnostic accuracy and patient outcomes in brain disease detection. JLK is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JLK stock

Interest Coverage Ratio of JLK is -18.02 in 2024.

Interest Coverage Ratio of JLK changed from -52.91 to -18.02, representing a -65.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio JLK since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's JLK with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — JLK

All Key Metrics — JLK